Author: "Barouki, R." - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Barouki, R."' showing total 428 results

Start Over Author "Barouki, R."

428 results on '"Barouki, R."'

1. Assessing the contribution of the chemical exposome to neurodegenerative disease

Author: Lefèvre-Arbogast, S., Chaker, J., Mercier, F., Barouki, R., Coumoul, X., Miller, G. W., David, A., and Samieri, C.
Published: 2024
Full Text: View/download PDF

2. New approach methodologies to enhance human health risk assessment of immunotoxic properties of chemicals - a PARC (Partnership for the Assessment of Risk from Chemicals) project

Author: Snapkow, I., Smith, N.M., Arnesdotter, E., Beekmann, K., Blanc, E.B., Braeuning, A., Corsini, E., Sollner Dolenc, M., Duivenvoorde, L.P.M., Eriksen, G.S., Franko, N., Galbiati, V., Gostner, J.M., Grova, N., Gutleb, A.C., Hargitai, R., Janssen, A.W.F., Krapf, S.A., Lindeman, B., Lumniczky, K., Maddalon, A., Mollerup, S., Parráková, L., Pierzchalski, Arkadiusz, Pieters, R.H.H., Silva, M.J., Solhaug, A., Staal, Y.C.M., Straumfors, A., Szatmári, T., Turner, J.D., Vandebriel, R.J., Zenclussen, Ana Claudia, Barouki, R., Snapkow, I., Smith, N.M., Arnesdotter, E., Beekmann, K., Blanc, E.B., Braeuning, A., Corsini, E., Sollner Dolenc, M., Duivenvoorde, L.P.M., Eriksen, G.S., Franko, N., Galbiati, V., Gostner, J.M., Grova, N., Gutleb, A.C., Hargitai, R., Janssen, A.W.F., Krapf, S.A., Lindeman, B., Lumniczky, K., Maddalon, A., Mollerup, S., Parráková, L., Pierzchalski, Arkadiusz, Pieters, R.H.H., Silva, M.J., Solhaug, A., Staal, Y.C.M., Straumfors, A., Szatmári, T., Turner, J.D., Vandebriel, R.J., Zenclussen, Ana Claudia, and Barouki, R.
Abstract: As a complex system governing and interconnecting numerous functions within the human body, the immune system is unsurprisingly susceptible to the impact of toxic chemicals. Toxicants can influence the immune system through a multitude of mechanisms, resulting in immunosuppression, hypersensitivity, increased risk of autoimmune diseases and cancer development. At present, the regulatory assessment of the immunotoxicity of chemicals relies heavily on rodent models and a limited number of Organisation for Economic Co-operation and Development (OECD) test guidelines, which only capture a fraction of potential toxic properties. Due to this limitation, various authorities, including the World Health Organization and the European Food Safety Authority have highlighted the need for the development of novel approaches without the use of animals for immunotoxicity testing of chemicals. In this paper, we present a concise overview of ongoing efforts dedicated to developing and standardizing methodologies for a comprehensive characterization of the immunotoxic effects of chemicals, which are performed under the EU-funded Partnership for the Assessment of Risk from Chemicals (PARC).
Published: 2024

3. L’exposome, un concept holistique et utile

Author: Barouki, R.
Published: 2020
Full Text: View/download PDF

4. A global research priority agenda to advance public health responses to fatty liver disease

Author: Lazarus, J, Mark, H, Allen, A, Arab, J, Carrieri, P, Noureddin, M, Alazawi, W, Alkhouri, N, Alqahtani, S, Arrese, M, Bataller, R, Berg, T, Brennan, P, Burra, P, Castro-Narro, G, Cortez-Pinto, H, Cusi, K, Dedes, N, Duseja, A, Francque, S, Hagstrom, H, Huang, T, Wajcman, D, Kautz, A, Kopka, C, Krag, A, Miller, V, Newsome, P, Rinella, M, Romero, D, Sarin, S, Silva, M, Spearman, C, Tsochatzis, E, Valenti, L, Villota-Rivas, M, Zelber-Sagi, S, Schattenberg, J, Wong, V, Younossi, Z, Aberg, F, Adams, L, Al-Naamani, K, Albadawy, R, Alexa, Z, Allison, M, Alnaser, F, Alswat, K, Alvares-da-Silva, M, Alvaro, D, Alves-Bezerra, M, Andrade, R, Anstee, Q, Awuku, Y, Baatarkhuu, O, Baffy, G, Bakieva, S, Bansal, M, Barouki, R, Batterham, R, Behling, C, Belfort-DeAguiar, R, Berzigotti, A, Betel, M, Bianco, C, Bosi, E, Boursier, J, Brunt, E, Bugianesi, E, Byrne, C, Cabrera Cabrejos, M, Caldwell, S, Carr, R, Castellanos Fernandez, M, Castera, L, Castillo-Lopez, M, Caussy, C, Cerda-Reyes, E, Ceriello, A, Chan, W, Chang, Y, Charatcharoenwitthaya, P, Chavez-Tapia, N, Chung, R, Colombo, M, Coppell, K, Cotrim, H, Craxi, A, Crespo, J, Dassanayake, A, Davidson, N, De Knegt, R, de Ledinghen, V, Demir, M, Desalegn, H, Diago, M, Dillon, J, Dimmig, B, Dirac, M, Dirchwolf, M, Dufour, J, Dvorak, K, Ekstedt, M, El-Kassas, M, Elsanousi, O, Elsharkawy, A, Elwakil, R, Eskridge, W, Eslam, M, Esmat, G, Fan, J, Ferraz, M, Flisiak, R, Fortin, D, Fouad, Y, Freidman, S, Fuchs, M, Gadano, A, Gastaldelli, A, Geerts, A, Geier, A, George, J, Gerber, L, Ghazinyan, H, Gheorghe, L, Kile, D, Girala, M, Boon Bee, G, Goossens, N, Graupera, I, Gronbaek, H, Hamid, S, Hebditch, V, Henry, Z, Hickman, I, Hobbs, L, Hocking, S, Hofmann, W, Idilman, R, Iruzubieta, P, Isaacs, S, Isakov, V, Ismail, M, Jamal, M, Jarvis, H, Jepsen, P, Jornayvaz, F, Sudhamshu, K, Kakizaki, S, Karpen, S, Kawaguchi, T, Keating, S, Khader, Y, Kim, S, Kim, W, Kleiner, D, Koek, G, Joseph Komas, N, Kondili, L, Koot, B, Korenjak, M, Kotsiliti, E, Koulla, Y, Kugelmas, C, Kugelmas, M, Labidi, A, Lange, N, Lavine, J, Lazo, M, Leite, N, Lin, H, Lkhagvaa, U, Long, M, Lopez-Jaramillo, P, Lozano, A, Macedo, M, Malekzadeh, R, Marchesini, G, Marciano, S, Martinez, K, Martinez Vazquez, S, Mateva, L, Mato, J, Nlombi, C, Mccary, A, Mcintyre, J, Mckee, M, Mendive, J, Mikolasevic, I, Miller, P, Milovanovic, T, Milton, T, Moreno-Alcantar, R, Morgan, T, Motala, A, Muris, J, Musso, C, Nava-Gonzalez, E, Negro, F, Nersesov, A, Neuschwander-Tetri, B, Nikolova, D, Norris, S, Novak, K, Ocama, P, Ong, J, Ong-Go, A, Onyekwere, C, Padilla, M, Pais, R, Pan, C, Panduro, A, Panigrahi, M, Papatheodoridis, G, Paruk, I, Patel, K, Goncalves, C, Figueroa, M, Perez-Escobar, J, Pericas, J, Perseghin, G, Pessoa, M, Petta, S, Marques Souza de Oliveira, C, Prabhakaran, D, Pyrsopoulous, N, Rabiee, A, Ramji, A, Ratziu, V, Ravendhran, N, Ray, K, Roden, M, Romeo, S, Romero-Gomez, M, Rotman, Y, Rouabhia, S, Rowe, I, Sadirova, S, Alkhatry, M, Salupere, R, Satapathy, S, Schwimmer, J, Sebastiani, G, Seim, L, Seki, Y, Serme, A, Shapiro, D, Sharvadze, L, Shaw, J, Shawa, I, Shenoy, T, Shibolet, O, Shimakawa, Y, Shubrook, J, Singh, S, Sinkala, E, Skladany, L, Skrypnyk, I, Song, M, Sookoian, S, Sridharan, K, Stefan, N, Stine, J, Stratakis, N, Sheriff, D, Sundaram, S, Svegliati-Baroni, G, Swain, M, Tacke, F, Taheri, S, Tan, S, Tapper, E, Targher, G, Tcaciuc, E, Thiele, M, Tiniakos, D, Tolmane, I, Torre, A, Torres, E, Treeprasertsuk, S, Trenell, M, Turcan, S, Turcanu, A, Valantinas, J, van Kleef, L, Velarde Ruiz Velasco, J, Vesterhus, M, Vilar-Gomez, E, Waked, I, Wattacheril, J, Wedemeyer, H, Wilkins, F, Willemse, J, Wong, R, Yilmaz, Y, Yki-Jarvinen, H, Yu, M, Yumuk, V, Zeybel, M, Zheng, K, Zheng, M, Lazarus J. V., Mark H. E., Allen A. M., Arab J. P., Carrieri P., Noureddin M., Alazawi W., Alkhouri N., Alqahtani S. A., Arrese M., Bataller R., Berg T., Brennan P. N., Burra P., Castro-Narro G. E., Cortez-Pinto H., Cusi K., Dedes N., Duseja A., Francque S. M., Hagstrom H., Huang T. T. -K., Wajcman D. I., Kautz A., Kopka C. J., Krag A., Miller V., Newsome P. N., Rinella M. E., Romero D., Sarin S. K., Silva M., Spearman C. W., Tsochatzis E. A., Valenti L., Villota-Rivas M., Zelber-Sagi S., Schattenberg J. M., Wong V. W. -S., Younossi Z. M., Aberg F., Adams L., Al-Naamani K., Albadawy R. M., Alexa Z., Allison M., Alnaser F. A., Alswat K., Alvares-da-Silva M. R., Alvaro D., Alves-Bezerra M., Andrade R. J., Anstee Q. M., Awuku Y. A., Baatarkhuu O., Baffy G., Bakieva S., Bansal M. B., Barouki R., Batterham R. L., Behling C., Belfort-DeAguiar R., Berzigotti A., Betel M., Bianco C., Bosi E., Boursier J., Brunt E. M., Bugianesi E., Byrne C. J., Cabrera Cabrejos M. C., Caldwell S., Carr R., Castellanos Fernandez M. I., Castera L., Castillo-Lopez M. G., Caussy C., Cerda-Reyes E., Ceriello A., Chan W. -K., Chang Y., Charatcharoenwitthaya P., Chavez-Tapia N., Chung R. T., Colombo M., Coppell K., Cotrim H. P., Craxi A., Crespo J., Dassanayake A., Davidson N. O., De Knegt R., de Ledinghen V., Demir M., Desalegn H., Diago M., Dillon J. F., Dimmig B., Dirac M. A., Dirchwolf M., Dufour J. -F., Dvorak K., Ekstedt M., El-Kassas M., Elsanousi O. M., Elsharkawy A. M., Elwakil R., Eskridge W., Eslam M., Esmat G., Fan J. -G., Ferraz M. L., Flisiak R., Fortin D., Fouad Y., Freidman S. L., Fuchs M., Gadano A., Gastaldelli A., Geerts A., Geier A., George J., Gerber L. H., Ghazinyan H., Gheorghe L., Kile D. G., Girala M., Boon Bee G. G., Goossens N., Graupera I., Gronbaek H., Hamid S., Hebditch V., Henry Z., Hickman I. J., Hobbs L. A., Hocking S. L., Hofmann W. P., Idilman R., Iruzubieta P., Isaacs S., Isakov V. A., Ismail M. H., Jamal M. H., Jarvis H., Jepsen P., Jornayvaz F., Sudhamshu K. C., Kakizaki S., Karpen S., Kawaguchi T., Keating S. E., Khader Y., Kim S. U., Kim W., Kleiner D. E., Koek G., Joseph Komas N. P., Kondili L. A., Koot B. G., Korenjak M., Kotsiliti E., Koulla Y., Kugelmas C., Kugelmas M., Labidi A., Lange N. F., Lavine J. E., Lazo M., Leite N., Lin H. -C., Lkhagvaa U., Long M. T., Lopez-Jaramillo P., Lozano A., Macedo M. P., Malekzadeh R., Marchesini G., Marciano S., Martinez K., Martinez Vazquez S. E., Mateva L., Mato J. M., Nlombi C. M., McCary A. G., McIntyre J., McKee M., Mendive J. M., Mikolasevic I., Miller P. S., Milovanovic T., Milton T., Moreno-Alcantar R., Morgan T. R., Motala A., Muris J., Musso C., Nava-Gonzalez E. J., Negro F., Nersesov A. V., Neuschwander-Tetri B. A., Nikolova D., Norris S., Novak K., Ocama P., Ong J. P., Ong-Go A., Onyekwere C., Padilla M., Pais R., Pan C., Panduro A., Panigrahi M. K., Papatheodoridis G., Paruk I., Patel K., Goncalves C. P., Figueroa M. P., Perez-Escobar J., Pericas J. M., Perseghin G., Pessoa M. G., Petta S., Marques Souza de Oliveira C. P., Prabhakaran D., Pyrsopoulous N., Rabiee A., Ramji A., Ratziu V., Ravendhran N., Ray K., Roden M., Romeo S., Romero-Gomez M., Rotman Y., Rouabhia S., Rowe I. A., Sadirova S., Alkhatry M. S., Salupere R., Satapathy S. K., Schwimmer J. B., Sebastiani G., Seim L., Seki Y., Serme A. K., Shapiro D., Sharvadze L., Shaw J. E., Shawa I. T., Shenoy T., Shibolet O., Shimakawa Y., Shubrook J. H., Singh S. P., Sinkala E., Skladany L., Skrypnyk I., Song M. J., Sookoian S., Sridharan K., Stefan N., Stine J. G., Stratakis N., Sheriff D. S., Sundaram S. S., Svegliati-Baroni G., Swain M. G., Tacke F., Taheri S., Tan S. -S., Tapper E. B., Targher G., Tcaciuc E., Thiele M., Tiniakos D., Tolmane I., Torre A., Torres E. A., Treeprasertsuk S., Trenell M., Turcan S., Turcanu A., Valantinas J., van Kleef L. A., Velarde Ruiz Velasco J. A., Vesterhus M., Vilar-Gomez E., Waked I., Wattacheril J., Wedemeyer H., Wilkins F., Willemse J., Wong R. J., Yilmaz Y., Yki-Jarvinen H., Yu M. -L., Yumuk V., Zeybel M., Zheng K. I., Zheng M. -H., Lazarus, J, Mark, H, Allen, A, Arab, J, Carrieri, P, Noureddin, M, Alazawi, W, Alkhouri, N, Alqahtani, S, Arrese, M, Bataller, R, Berg, T, Brennan, P, Burra, P, Castro-Narro, G, Cortez-Pinto, H, Cusi, K, Dedes, N, Duseja, A, Francque, S, Hagstrom, H, Huang, T, Wajcman, D, Kautz, A, Kopka, C, Krag, A, Miller, V, Newsome, P, Rinella, M, Romero, D, Sarin, S, Silva, M, Spearman, C, Tsochatzis, E, Valenti, L, Villota-Rivas, M, Zelber-Sagi, S, Schattenberg, J, Wong, V, Younossi, Z, Aberg, F, Adams, L, Al-Naamani, K, Albadawy, R, Alexa, Z, Allison, M, Alnaser, F, Alswat, K, Alvares-da-Silva, M, Alvaro, D, Alves-Bezerra, M, Andrade, R, Anstee, Q, Awuku, Y, Baatarkhuu, O, Baffy, G, Bakieva, S, Bansal, M, Barouki, R, Batterham, R, Behling, C, Belfort-DeAguiar, R, Berzigotti, A, Betel, M, Bianco, C, Bosi, E, Boursier, J, Brunt, E, Bugianesi, E, Byrne, C, Cabrera Cabrejos, M, Caldwell, S, Carr, R, Castellanos Fernandez, M, Castera, L, Castillo-Lopez, M, Caussy, C, Cerda-Reyes, E, Ceriello, A, Chan, W, Chang, Y, Charatcharoenwitthaya, P, Chavez-Tapia, N, Chung, R, Colombo, M, Coppell, K, Cotrim, H, Craxi, A, Crespo, J, Dassanayake, A, Davidson, N, De Knegt, R, de Ledinghen, V, Demir, M, Desalegn, H, Diago, M, Dillon, J, Dimmig, B, Dirac, M, Dirchwolf, M, Dufour, J, Dvorak, K, Ekstedt, M, El-Kassas, M, Elsanousi, O, Elsharkawy, A, Elwakil, R, Eskridge, W, Eslam, M, Esmat, G, Fan, J, Ferraz, M, Flisiak, R, Fortin, D, Fouad, Y, Freidman, S, Fuchs, M, Gadano, A, Gastaldelli, A, Geerts, A, Geier, A, George, J, Gerber, L, Ghazinyan, H, Gheorghe, L, Kile, D, Girala, M, Boon Bee, G, Goossens, N, Graupera, I, Gronbaek, H, Hamid, S, Hebditch, V, Henry, Z, Hickman, I, Hobbs, L, Hocking, S, Hofmann, W, Idilman, R, Iruzubieta, P, Isaacs, S, Isakov, V, Ismail, M, Jamal, M, Jarvis, H, Jepsen, P, Jornayvaz, F, Sudhamshu, K, Kakizaki, S, Karpen, S, Kawaguchi, T, Keating, S, Khader, Y, Kim, S, Kim, W, Kleiner, D, Koek, G, Joseph Komas, N, Kondili, L, Koot, B, Korenjak, M, Kotsiliti, E, Koulla, Y, Kugelmas, C, Kugelmas, M, Labidi, A, Lange, N, Lavine, J, Lazo, M, Leite, N, Lin, H, Lkhagvaa, U, Long, M, Lopez-Jaramillo, P, Lozano, A, Macedo, M, Malekzadeh, R, Marchesini, G, Marciano, S, Martinez, K, Martinez Vazquez, S, Mateva, L, Mato, J, Nlombi, C, Mccary, A, Mcintyre, J, Mckee, M, Mendive, J, Mikolasevic, I, Miller, P, Milovanovic, T, Milton, T, Moreno-Alcantar, R, Morgan, T, Motala, A, Muris, J, Musso, C, Nava-Gonzalez, E, Negro, F, Nersesov, A, Neuschwander-Tetri, B, Nikolova, D, Norris, S, Novak, K, Ocama, P, Ong, J, Ong-Go, A, Onyekwere, C, Padilla, M, Pais, R, Pan, C, Panduro, A, Panigrahi, M, Papatheodoridis, G, Paruk, I, Patel, K, Goncalves, C, Figueroa, M, Perez-Escobar, J, Pericas, J, Perseghin, G, Pessoa, M, Petta, S, Marques Souza de Oliveira, C, Prabhakaran, D, Pyrsopoulous, N, Rabiee, A, Ramji, A, Ratziu, V, Ravendhran, N, Ray, K, Roden, M, Romeo, S, Romero-Gomez, M, Rotman, Y, Rouabhia, S, Rowe, I, Sadirova, S, Alkhatry, M, Salupere, R, Satapathy, S, Schwimmer, J, Sebastiani, G, Seim, L, Seki, Y, Serme, A, Shapiro, D, Sharvadze, L, Shaw, J, Shawa, I, Shenoy, T, Shibolet, O, Shimakawa, Y, Shubrook, J, Singh, S, Sinkala, E, Skladany, L, Skrypnyk, I, Song, M, Sookoian, S, Sridharan, K, Stefan, N, Stine, J, Stratakis, N, Sheriff, D, Sundaram, S, Svegliati-Baroni, G, Swain, M, Tacke, F, Taheri, S, Tan, S, Tapper, E, Targher, G, Tcaciuc, E, Thiele, M, Tiniakos, D, Tolmane, I, Torre, A, Torres, E, Treeprasertsuk, S, Trenell, M, Turcan, S, Turcanu, A, Valantinas, J, van Kleef, L, Velarde Ruiz Velasco, J, Vesterhus, M, Vilar-Gomez, E, Waked, I, Wattacheril, J, Wedemeyer, H, Wilkins, F, Willemse, J, Wong, R, Yilmaz, Y, Yki-Jarvinen, H, Yu, M, Yumuk, V, Zeybel, M, Zheng, K, Zheng, M, Lazarus J. V., Mark H. E., Allen A. M., Arab J. P., Carrieri P., Noureddin M., Alazawi W., Alkhouri N., Alqahtani S. A., Arrese M., Bataller R., Berg T., Brennan P. N., Burra P., Castro-Narro G. E., Cortez-Pinto H., Cusi K., Dedes N., Duseja A., Francque S. M., Hagstrom H., Huang T. T. -K., Wajcman D. I., Kautz A., Kopka C. J., Krag A., Miller V., Newsome P. N., Rinella M. E., Romero D., Sarin S. K., Silva M., Spearman C. W., Tsochatzis E. A., Valenti L., Villota-Rivas M., Zelber-Sagi S., Schattenberg J. M., Wong V. W. -S., Younossi Z. M., Aberg F., Adams L., Al-Naamani K., Albadawy R. M., Alexa Z., Allison M., Alnaser F. A., Alswat K., Alvares-da-Silva M. R., Alvaro D., Alves-Bezerra M., Andrade R. J., Anstee Q. M., Awuku Y. A., Baatarkhuu O., Baffy G., Bakieva S., Bansal M. B., Barouki R., Batterham R. L., Behling C., Belfort-DeAguiar R., Berzigotti A., Betel M., Bianco C., Bosi E., Boursier J., Brunt E. M., Bugianesi E., Byrne C. J., Cabrera Cabrejos M. C., Caldwell S., Carr R., Castellanos Fernandez M. I., Castera L., Castillo-Lopez M. G., Caussy C., Cerda-Reyes E., Ceriello A., Chan W. -K., Chang Y., Charatcharoenwitthaya P., Chavez-Tapia N., Chung R. T., Colombo M., Coppell K., Cotrim H. P., Craxi A., Crespo J., Dassanayake A., Davidson N. O., De Knegt R., de Ledinghen V., Demir M., Desalegn H., Diago M., Dillon J. F., Dimmig B., Dirac M. A., Dirchwolf M., Dufour J. -F., Dvorak K., Ekstedt M., El-Kassas M., Elsanousi O. M., Elsharkawy A. M., Elwakil R., Eskridge W., Eslam M., Esmat G., Fan J. -G., Ferraz M. L., Flisiak R., Fortin D., Fouad Y., Freidman S. L., Fuchs M., Gadano A., Gastaldelli A., Geerts A., Geier A., George J., Gerber L. H., Ghazinyan H., Gheorghe L., Kile D. G., Girala M., Boon Bee G. G., Goossens N., Graupera I., Gronbaek H., Hamid S., Hebditch V., Henry Z., Hickman I. J., Hobbs L. A., Hocking S. L., Hofmann W. P., Idilman R., Iruzubieta P., Isaacs S., Isakov V. A., Ismail M. H., Jamal M. H., Jarvis H., Jepsen P., Jornayvaz F., Sudhamshu K. C., Kakizaki S., Karpen S., Kawaguchi T., Keating S. E., Khader Y., Kim S. U., Kim W., Kleiner D. E., Koek G., Joseph Komas N. P., Kondili L. A., Koot B. G., Korenjak M., Kotsiliti E., Koulla Y., Kugelmas C., Kugelmas M., Labidi A., Lange N. F., Lavine J. E., Lazo M., Leite N., Lin H. -C., Lkhagvaa U., Long M. T., Lopez-Jaramillo P., Lozano A., Macedo M. P., Malekzadeh R., Marchesini G., Marciano S., Martinez K., Martinez Vazquez S. E., Mateva L., Mato J. M., Nlombi C. M., McCary A. G., McIntyre J., McKee M., Mendive J. M., Mikolasevic I., Miller P. S., Milovanovic T., Milton T., Moreno-Alcantar R., Morgan T. R., Motala A., Muris J., Musso C., Nava-Gonzalez E. J., Negro F., Nersesov A. V., Neuschwander-Tetri B. A., Nikolova D., Norris S., Novak K., Ocama P., Ong J. P., Ong-Go A., Onyekwere C., Padilla M., Pais R., Pan C., Panduro A., Panigrahi M. K., Papatheodoridis G., Paruk I., Patel K., Goncalves C. P., Figueroa M. P., Perez-Escobar J., Pericas J. M., Perseghin G., Pessoa M. G., Petta S., Marques Souza de Oliveira C. P., Prabhakaran D., Pyrsopoulous N., Rabiee A., Ramji A., Ratziu V., Ravendhran N., Ray K., Roden M., Romeo S., Romero-Gomez M., Rotman Y., Rouabhia S., Rowe I. A., Sadirova S., Alkhatry M. S., Salupere R., Satapathy S. K., Schwimmer J. B., Sebastiani G., Seim L., Seki Y., Serme A. K., Shapiro D., Sharvadze L., Shaw J. E., Shawa I. T., Shenoy T., Shibolet O., Shimakawa Y., Shubrook J. H., Singh S. P., Sinkala E., Skladany L., Skrypnyk I., Song M. J., Sookoian S., Sridharan K., Stefan N., Stine J. G., Stratakis N., Sheriff D. S., Sundaram S. S., Svegliati-Baroni G., Swain M. G., Tacke F., Taheri S., Tan S. -S., Tapper E. B., Targher G., Tcaciuc E., Thiele M., Tiniakos D., Tolmane I., Torre A., Torres E. A., Treeprasertsuk S., Trenell M., Turcan S., Turcanu A., Valantinas J., van Kleef L. A., Velarde Ruiz Velasco J. A., Vesterhus M., Vilar-Gomez E., Waked I., Wattacheril J., Wedemeyer H., Wilkins F., Willemse J., Wong R. J., Yilmaz Y., Yki-Jarvinen H., Yu M. -L., Yumuk V., Zeybel M., Zheng K. I., and Zheng M. -H.
Abstract: Background & aims: An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods: Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a three-day in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results: The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a super-majority of agreement (>66.7% ‘agree’), 13 priorities had [removed]90% combined agreement. Conclusions: Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community's efforts to advance and accelerate responses to this widespread and fast-growing public health threat. Impact and implications: An estimated 38% of adults and 13% o
Published: 2023

5. Polluants, perturbateurs endocriniens et obésité

Author: Kim, M.J., primary, Barouki, R., additional, and Chevalier, N., additional
Published: 2021
Full Text: View/download PDF

6. Innovative tools and methods for toxicity testing within PARC work package 5 on hazard assessment

Author: De Castelbajac, T., Aiello, K., Arenas, C.G., Svingen, T., Ramhøj, L., Zalko, D., Barouki, R., Vanhaecke, T., Rogiers, V., Audebert, M., Oelgeschlaeger, M., Braeuning, A., Blanc, E., Tal, Tamara, Rüegg, J., Fritsche, E., Marx-Stoelting, P., Rivière, G., De Castelbajac, T., Aiello, K., Arenas, C.G., Svingen, T., Ramhøj, L., Zalko, D., Barouki, R., Vanhaecke, T., Rogiers, V., Audebert, M., Oelgeschlaeger, M., Braeuning, A., Blanc, E., Tal, Tamara, Rüegg, J., Fritsche, E., Marx-Stoelting, P., and Rivière, G.
Abstract: New approach methodologies (NAMs) have the potential to become a major component of regulatory risk assessment, however, their actual implementation is challenging. The European Partnership for the Assessment of Risks from Chemicals (PARC) was designed to address many of the challenges that exist for the development and implementation of NAMs in modern chemical risk assessment. PARC’s proximity to national and European regulatory agencies is envisioned to ensure that all the research and innovation projects that are initiated within PARC agree with actual regulatory needs. One of the main aims of PARC is to develop innovative methodologies that will directly aid chemical hazard identification, risk assessment, and regulation/policy. This will facilitate the development of NAMs for use in risk assessment, as well as the transition from an endpoint-based animal testing strategy to a more mechanistic-based NAMs testing strategy, as foreseen by the Tox21 and the EU Chemical’s Strategy for Sustainability. This work falls under work package 5 (WP5) of the PARC initiative. There are three different tasks within WP5, and this paper is a general overview of the five main projects in the Task 5.2 ‘Innovative Tools and methods for Toxicity Testing,’ with a focus on Human Health. This task will bridge essential regulatory data gaps pertaining to the assessment of toxicological prioritized endpoints such as non-genotoxic carcinogenicity, immunotoxicity, endocrine disruption (mainly thyroid), metabolic disruption, and (developmental and adult) neurotoxicity, thereby leveraging OECD’s and PARC’s AOP frameworks. This is intended to provide regulatory risk assessors and industry stakeholders with relevant, affordable and reliable assessment tools that will ultimately contribute to the application of next-generation risk assessment (NGRA) in Europe and worldwide.
Published: 2023

7. PL04-01 Challenges and opportunities for regulatory toxicology under the chemicals strategy for sustainability

Author: Younes, M., primary, Wallace, H., additional, Herzler, M., additional, de Knecht, J., additional, Barouki, R., additional, and Schutte, K., additional
Published: 2022
Full Text: View/download PDF

8. Putative Biomarkers of Environmental Enteric Disease Fail to Correlate in a Cross-Sectional Study in Two Study Sites in Sub-Saharan Africa

Author: Vonaesch, P., Winkel, M., Kapel, N., Nestoret, A., Barbot-Trystram, L., Pontoizeau, C., Barouki, R., Rakotondrainipiana, M., Kandou, K., Andriamanantena, Z., Andrianonimiadana, L., Habib, A., Rodriguez-Pozo, A., Hasan, M., Vigan-Womas, I., Collard, J. M., Gody, J. C., Djorie, S., Sansonetti, P. J., Randremanana, R. V., On Behalf Of The Afribiota Investigators, Pathogénie microbienne moléculaire, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Lausanne = University of Lausanne (UNIL), Swiss Tropical and Public Health Institute [Basel], University of Basel (Unibas), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut Pasteur de Madagascar, Réseau International des Instituts Pasteur (RIIP), Institut Pasteur de Bangui, Cytometrie et Biomarqueurs – Cytometry and Biomarkers (UTechS CB), Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), Centre National Hospitalier Universitaire [Bangui] (CNHUB), This project was funded by the Total Foundation, Institut Pasteur, the Bill and Melinda Gates Foundation (OPP1204689), the Fondation Petram and a donation by the Odyssey Re-Insurance company. PV was supported by an Early Postdoctoral Fellowship (P2EZP3_152159), an Advanced Postdoctoral Fellowship (P300PA_177876) as well as a Return Grant (P3P3PA_17877) from the Swiss National Science Foundation, a Roux-Cantarini Fellowship (award year: 2016), a L’Oréal-UNESCO for Women in Science France Fellowship (award year: 2017) and an Excellence Scholarship from the University of Basel (Forschungsfonds, award year: 2019)., and We wish to thank all implicated children and their families, the AFRIBIOTA Consortium, the participating hospitals in Bangui and Antananarivo, Institut Pasteur, Institut Pasteur de Madagascar and Institut Pasteur de Bangui and members of the scientific advisory board for their continuous support. Furthermore, we wish to thank the Centre de Recherche Translationelle and the Direction Internationale of the Institut Pasteur, and especially Paméla Palvadeau, Jane Lynda Deuve, Cécile Artaud, Nathalie Jolly, Sophie Jarrijon, Mamy Ratsialonina, and Jean-François Damaras for precious help in setting-up and steering the AFRIBIOTA project. We would also like to thank Jean-Marc Collard, Pierre-Alain Rubbo, Dieu-Merci Welekoi-Yapondo, Lova Andrianonimiadana, Laurence Arowas and Marie-Noelle Ungeheuer for managing the AFRIBIOTA biobank. Furthermore, we would like to thank the Centre d’Immunologie Humaine of the Institut Pasteur, especially Tarshana Stephen and Esma Karkeni for help with setting-up the LUMINEX assays at their platform.
Subjects: alpha-1-antitrypsin, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, calprotectin, Environmental Illness, insulin-like growth factor, stunted child growth, Intestine, Small, Humans, Africa South of the Sahara, Growth Disorders, Nutrition and Dietetics, Sub-Saharan Africa, environmental enteric dysfunction, anemia, biomarker, citrulline, lactulose-mannitol test, [SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology, Intestinal Diseases, C-Reactive Protein, Cross-Sectional Studies, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, Child, Preschool, [SDV.IMM]Life Sciences [q-bio]/Immunology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Leukocyte L1 Antigen Complex, Biomarkers, Food Science
Abstract: International audience; Environmental enteric dysfunction (EED) is an elusive, inflammatory syndrome of the small intestine thought to be associated with enterocyte loss and gut leakiness and lead to stunted child growth. To date, the gold standard for diagnosis is small intestine biopsy followed by histology. Several putative biomarkers for EED have been proposed and are widely used in the field. Here, we assessed in a cross-sectional study of children aged 2–5 years for a large set of biomarkers including markers of protein exudation (duodenal and fecal alpha-1-antitrypsin (AAT)), inflammation (duodenal and fecal calprotectin, duodenal, fecal and blood immunoglobulins, blood cytokines, C-reactive protein (CRP)), gut permeability (endocab, lactulose-mannitol ratio), enterocyte mass (citrulline) and general nutritional status (branched-chain amino acids (BCAA), insulin-like growth factor) in a group of 804 children in two Sub-Saharan countries. We correlated these markers with each other and with anemia in stunted and non-stunted children. AAT and calprotectin, CRP and citrulline and citrulline and BCAA correlated with each other. Furthermore, BCAA, citrulline, ferritin, fecal calprotectin and CRP levels were correlated with hemoglobin levels. Our results show that while several of the biomarkers are associated with anemia, there is little correlation between the different biomarkers. Better biomarkers and a better definition of EED are thus urgently needed.
Published: 2022
Full Text: View/download PDF

9. Application of AOPs to assist regulatory assessment of chemical risks – Case studies, needs and recommendations

Author: Bajard, L., Adamovsky, O., Audouze, K., Baken, K., Barouki, R., Beltman, J.B., Beronius, A., Bonefeld-Jørgensen, E.C., Cano-Sancho, G., de Baat, M.L., Di Tillio, F., Fernández, M.F., FitzGerald, R.E., Gundacker, C., Hernández, A.F., Hilscherova, K., Karakitsios, S., Kuchovska, E., Long, M., Luijten, M., Majid, S., Marx-Stoelting, P., Mustieles, V., Negi, C.K., Sarigiannis, D., Scholz, Stefan, Sovadinova, I., Stierum, R., Tanabe, S., Tollefsen, K.E., van den Brand, A.D., Vogs, C., Wielsøe, M., Wittwehr, C., Blaha, L., Bajard, L., Adamovsky, O., Audouze, K., Baken, K., Barouki, R., Beltman, J.B., Beronius, A., Bonefeld-Jørgensen, E.C., Cano-Sancho, G., de Baat, M.L., Di Tillio, F., Fernández, M.F., FitzGerald, R.E., Gundacker, C., Hernández, A.F., Hilscherova, K., Karakitsios, S., Kuchovska, E., Long, M., Luijten, M., Majid, S., Marx-Stoelting, P., Mustieles, V., Negi, C.K., Sarigiannis, D., Scholz, Stefan, Sovadinova, I., Stierum, R., Tanabe, S., Tollefsen, K.E., van den Brand, A.D., Vogs, C., Wielsøe, M., Wittwehr, C., and Blaha, L.
Abstract: While human regulatory risk assessment (RA) still largely relies on animal studies, new approach methodologies (NAMs) based on in vitro, in silico or non-mammalian alternative models are increasingly used to evaluate chemical hazards. Moreover, human epidemiological studies with biomarkers of effect (BoE) also play an invaluable role in identifying health effects associated with chemical exposures. To move towards the next generation risk assessment (NGRA), it is therefore crucial to establish bridges between NAMs and standard approaches, and to establish processes for increasing mechanistically-based biological plausibility in human studies. The Adverse Outcome Pathway (AOP) framework constitutes an important tool to address these needs but, despite a significant increase in knowledge and awareness, the use of AOPs in chemical RA remains limited. The objective of this paper is to address issues related to using AOPs in a regulatory context from various perspectives as it was discussed in a workshop organized within the European Union partnerships HBM4EU and PARC in spring 2022. The paper presents examples where the AOP framework has been proven useful for the human RA process, particularly in hazard prioritization and characterization, in integrated approaches to testing and assessment (IATA), and in the identification and validation of BoE in epidemiological studies. Nevertheless, several limitations were identified that hinder the optimal usability and acceptance of AOPs by the regulatory community including the lack of quantitative information on response-response relationships and of efficient ways to map chemical data (exposure and toxicity) onto AOPs. The paper summarizes suggestions, ongoing initiatives and third-party tools that may help to overcome these obstacles and thus assure better implementation of AOPs in the NGRA.
Published: 2022

10. Cytosolic aspartate aminotransferase : tissue-specific hormonal regulation of a housekeeping gene promoter

Author: Barouki, R., Garlatti, M., Feilleux-Duché, S., Toussaint, C., Aggerbeck, M., Hanoune, J., Marino, G., editor, Sannia, G., editor, and Bossa, F., editor
Published: 1994
Full Text: View/download PDF

11. Chapitre 21 - Polluants, perturbateurs endocriniens et obésité

Author: Kim, M.J., Barouki, R., and Chevalier, N.
Published: 2021
Full Text: View/download PDF

12. The aryl hydrocarbon receptor regulates focal adhesion sites through a non-genomic FAK/Src pathway

Author: Tomkiewicz, C, Herry, L, Bui, L-C, Métayer, C, Bourdeloux, M, Barouki, R, and Coumoul, X
Published: 2013
Full Text: View/download PDF

13. A call for urgent action to safeguard our planet and our health in line with the helsinki declaration

Author: Halonen, J.I., Erhola, M., Furman, E., Haahtela, T., Jousilahti, P., Barouki, R., Bergman, Å., Billo, N.E., Fuller, R., Haines, A., Kogevinas, M., Kolossa-Gehring, M., Krauze, K., Lanki, T., Vicente, J.L., Messerli, P., Nieuwenhuijsen, M., Paloniemi, R., Peters, Annette, Posch, K.-H., Timonen, P., Vermeulen, R., Virtanen, S.M., Bousquet, J., Antó, J.M., Halonen, J.I., Erhola, M., Furman, E., Haahtela, T., Jousilahti, P., Barouki, R., Bergman, Å., Billo, N.E., Fuller, R., Haines, A., Kogevinas, M., Kolossa-Gehring, M., Krauze, K., Lanki, T., Vicente, J.L., Messerli, P., Nieuwenhuijsen, M., Paloniemi, R., Peters, Annette, Posch, K.-H., Timonen, P., Vermeulen, R., Virtanen, S.M., Bousquet, J., and Antó, J.M.
Abstract: In 2015, the Rockefeller Foundation-Lancet Commission launched a report introducing a novel approach called Planetary Health and proposed a concept, a strategy and a course of action. To discuss the concept of Planetary Health in the context of Europe, a conference entitled: “Europe That Protects: Safeguarding Our Planet, Safeguarding Our Health” was held in Helsinki in December 2019. The conference participants concluded with a need for action to support Planetary Health during the 2020s. The Helsinki Declaration emphasizes the urgency to act as scientific evidence shows that human activities are causing climate change, biodiversity loss, land degradation, overuse of natural resources and pollution. They threaten the health and safety of human kind. Global, regional, national, local and individual initiatives are called for and multidisciplinary and multisectorial actions and measures are needed. A framework for an action plan is suggested that can be modified for local needs. Accordingly, a shift from fragmented approaches to policy and practice towards systematic actions will promote human health and health of the planet. Systems thinking will feed into conserving nature and biodiversity, and into halting climate change. The Planetary Health paradigm ‒ the health of human civilization and the state of natural systems on which it depends ‒ must become the driver for all policies.
Published: 2021

14. A call for urgent action to safeguard our planet and our health in line with the helsinki declaration

Author: IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Halonen, J.I., Erhola, M., Furman, E., Haahtela, T., Jousilahti, P., Barouki, R., Bergman, Å., Billo, N.E., Fuller, R., Haines, A., Kogevinas, M., Kolossa-Gehring, M., Krauze, K., Lanki, T., Vicente, J.L., Messerli, P., Nieuwenhuijsen, M., Paloniemi, R., Peters, Annette, Posch, K.-H., Timonen, P., Vermeulen, R., Virtanen, S.M., Bousquet, J., Antó, J.M., IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Halonen, J.I., Erhola, M., Furman, E., Haahtela, T., Jousilahti, P., Barouki, R., Bergman, Å., Billo, N.E., Fuller, R., Haines, A., Kogevinas, M., Kolossa-Gehring, M., Krauze, K., Lanki, T., Vicente, J.L., Messerli, P., Nieuwenhuijsen, M., Paloniemi, R., Peters, Annette, Posch, K.-H., Timonen, P., Vermeulen, R., Virtanen, S.M., Bousquet, J., and Antó, J.M.
Published: 2021

15. A call for urgent action to safeguard our planet and our health in line with the helsinki declaration

Author: Halonen, J.I., Erhola, M., Furman, E., Haahtela, T., Jousilahti, P., Barouki, R., Bergman, Å., Billo, N.E., Fuller, R., Haines, A., Kogevinas, M., Kolossa-Gehring, M., Krauze, K., Lanki, T., Vicente, J.L., Messerli, P., Nieuwenhuijsen, M., Paloniemi, R., Peters, Annette, Posch, K.-H., Timonen, P., Vermeulen, R., Virtanen, S.M., Bousquet, J., Antó, J.M., IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Päijät-Häme Welfare Consortium, HYKS erva, HUS Inflammation Center, Department of Dermatology, Allergology and Venereology, Tampere University, Health Sciences, Tays Research Services, Department of Paediatrics, IRAS OH Epidemiology Chemical Agents, and dIRAS RA-2
Subjects: Air pollution, Planets, Context (language use), 010501 environmental sciences, Safeguarding, Public administration, 01 natural sciences, Biochemistry, Helsinki declaration, Scientific evidence, 03 medical and health sciences, 0302 clinical medicine, Environmental Science(all), Planetary health, Political science, 11. Sustainability, Humans, Climate change, Systems thinking, 030212 general & internal medicine, EXPOSURE, ENVIRONMENTAL BIODIVERSITY, Ecosystem, 0105 earth and related environmental sciences, General Environmental Science, Helsinki Declaration, Chemical pollution, Air Pollution, Chemical Pollution, Climate Change, Nature, Planetary Health, Urbanization, AIR-POLLUTION, 15. Life on land, Natural resource, humanities, 3142 Public health care science, environmental and occupational health, 3. Good health, 3141 Health care science, Europe, ALLERGY, Action (philosophy), 13. Climate action, Action plan, DISEASES, 316 Nursing
Abstract: In 2015, the Rockefeller Foundation-Lancet Commission launched a report introducing a novel approach called Planetary Health and proposed a concept, a strategy and a course of action. To discuss the concept of Planetary Health in the context of Europe, a conference entitled: "Europe That Protects: Safeguarding Our Planet, Safeguarding Our Health" was held in Helsinki in December 2019. The conference participants concluded with a need for action to support Planetary Health during the 2020s. The Helsinki Declaration emphasizes the urgency to act as scientific evidence shows that human activities are causing climate change, biodiversity loss, land degradation, overuse of natural resources and pollution. They threaten the health and safety of human kind. Global, regional, national, local and individual initiatives are called for and multidisciplinary and multisectorial actions and measures are needed. A framework for an action plan is suggested that can be modified for local needs. Accordingly, a shift from fragmented approaches to policy and practice towards systematic actions will promote human health and health of the planet. Systems thinking will feed into conserving nature and biodiversity, and into halting climate change. The Planetary Health paradigm ‒ the health of human civilization and the state of natural systems on which it depends ‒ must become the driver for all policies. publishedVersion Non
Published: 2020

16. Evaluation of Calcineurin Activity as a Biomarker of the State of Immunosuppression in Heart-Transplanted Patients.: Abstract# B777

Author: Sanquer, S., Varnous, S., Vermes, E., Lena, C., Herry, L., Niarra, R., Guillemain, R., Barouki, R., and Amrein, C.
Published: 2014

17. Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity

Author: Bui, L -C, Tomkiewicz, C, Chevallier, A, Pierre, S, Bats, A -S, Mota, S, Raingeaud, J, Pierre, J, Diry, M, Transy, C, Garlatti, M, Barouki, R, and Coumoul, X
Published: 2009
Full Text: View/download PDF

18. Potential toxicity of metal trace elements from food in children

Author: Bocquet, A., primary, Barouki, R., additional, Briend, A., additional, Chouraqui, J.-P., additional, Darmaun, D., additional, Feillet, F., additional, Frelut, M.-L., additional, Guimber, D., additional, Lapillonne, A., additional, Peretti, N., additional, Rozé, J.-C., additional, Simeoni, U., additional, Turck, D., additional, and Dupont, C., additional
Published: 2021
Full Text: View/download PDF

19. The Helsinki Declaration 2020: Europe that protects

Author: Halonen, J.I., Erhola, M., Furman, E., Haahtela, T., Jousilahti, P., Barouki, R., Bergman, Å., Billo, N.E., Fuller, R., Haines, A., Kogevinas, M., Kolossa-Gehring, M., Krauze, K., Lanki, T., Vicente, J.L., Messerli, P., Nieuwenhuijsen, M., Paloniemi, R., Peters, A., Posch, K.-H., Timonen, P., Vermeulen, R., Virtanen, S.M., Bousquet, J., Antó, J.M., Sub Nanophotonics, IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Sub Nanophotonics, IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Tampere University, Health Sciences, Department of Paediatrics, and Tays Research Services
Subjects: Economic growth, 2019-20 coronavirus outbreak, Health (social science), Coronavirus disease 2019 (COVID-19), Earth, Planet, Climate Change, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Medicine (miscellaneous), Climate change, Public policy, Medi ambient, Public Policy, Environment, Global Health, Health(social science), Helsinki declaration, 03 medical and health sciences, 0302 clinical medicine, Urban planning, Air Pollution, Political science, Global health, Humans, 030212 general & internal medicine, City Planning, lcsh:Environmental sciences, Helsinki Declaration, lcsh:GE1-350, Salut mundial, Health Policy, Smoking, Public Health, Environmental and Occupational Health, COVID-19, 3142 Public health care science, environmental and occupational health, Europe, 030228 respiratory system, Canvis climàtics
Abstract: publishedVersion Non
Published: 2020

20. Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism

Author: Diry, M, Tomkiewicz, C, Koehle, C, Coumoul, X, Bock, K Walter, Barouki, R, and Transy, C
Published: 2006
Full Text: View/download PDF

21. The Helsinki Declaration 2020: Europe that protects

Author: Sub Nanophotonics, IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Halonen, J.I., Erhola, M., Furman, E., Haahtela, T., Jousilahti, P., Barouki, R., Bergman, Å., Billo, N.E., Fuller, R., Haines, A., Kogevinas, M., Kolossa-Gehring, M., Krauze, K., Lanki, T., Vicente, J.L., Messerli, P., Nieuwenhuijsen, M., Paloniemi, R., Peters, A., Posch, K.-H., Timonen, P., Vermeulen, R., Virtanen, S.M., Bousquet, J., Antó, J.M., Sub Nanophotonics, IRAS OH Epidemiology Chemical Agents, dIRAS RA-2, Halonen, J.I., Erhola, M., Furman, E., Haahtela, T., Jousilahti, P., Barouki, R., Bergman, Å., Billo, N.E., Fuller, R., Haines, A., Kogevinas, M., Kolossa-Gehring, M., Krauze, K., Lanki, T., Vicente, J.L., Messerli, P., Nieuwenhuijsen, M., Paloniemi, R., Peters, A., Posch, K.-H., Timonen, P., Vermeulen, R., Virtanen, S.M., Bousquet, J., and Antó, J.M.
Published: 2020

22. Suspect and non-targeted screening of chemicals of emerging concern for human biomonitoring, environmental health studies and support to risk assessment: From promises to challenges and harmonisation issues

Author: Pourchet, M., Debrauwer, L., Klanova, J., Price, E.J., Covaci, A., Caballero‑Casero, N., Oberacher, H., Lamoree, M., Damont, A., Fenaille, F., Vlaanderen, J., Meijer, J., Krauss, Martin, Sarigiannis, D., Barouki, R., Le Bizec, B., Antignac, J.-P., Pourchet, M., Debrauwer, L., Klanova, J., Price, E.J., Covaci, A., Caballero‑Casero, N., Oberacher, H., Lamoree, M., Damont, A., Fenaille, F., Vlaanderen, J., Meijer, J., Krauss, Martin, Sarigiannis, D., Barouki, R., Le Bizec, B., and Antignac, J.-P.
Abstract: Large-scale suspect and non-targeted screening approaches based on high-resolution mass spectrometry (HRMS) are today available for chemical profiling and holistic characterisation of biological samples. These advanced techniques allow the simultaneous detection of a large number of chemical features, including markers of human chemical exposure. Such markers are of interest for biomonitoring, environmental health studies and support to risk assessment. Furthermore, these screening approaches have the promising capability to detect chemicals of emerging concern (CECs), document the extent of human chemical exposure, generate new research hypotheses and provide early warning support to policy. Whilst of growing importance in the environment and food safety areas, respectively, CECs remain poorly addressed in the field of human biomonitoring. This shortfall is due to several scientific and methodological reasons, including a global lack of harmonisation. In this context, the main aim of this paper is to present an overview of the basic principles, promises and challenges of suspect and non-targeted screening approaches applied to human samples as this specific field introduce major specificities compared to other fields. Focused on liquid chromatography coupled to HRMS-based data acquisition methods, this overview addresses all steps of these new analytical workflows. Beyond this general picture, the main activities carried out on this topic within the particular framework of the European Human Biomonitoring initiative (project HBM4EU, 2017–2021) are described, with an emphasis on harmonisation measures.
Published: 2020

23. Le tissu adipeux : stockage, source et cible des polluants

Author: Barouki, R., primary and Clément, K., additional
Published: 2013
Full Text: View/download PDF

24. Effects of Endocrine Disruptors on Steroidogenic Enzymes Gene Expression and on Aromatase Activity in Two Human Cell Lines.

Author: Quignot, N, primary, Desmots, S, additional, Barouki, R, additional, and Lemazurier, E, additional
Published: 2010
Full Text: View/download PDF

25. Setting Occupational Health Research Priorities in Europe: the HERA Project

Author: Turner, M.C., primary, Pearce, N., additional, Mehlum, I.S., additional, Straif, K., additional, Vermeulen, R., additional, Barouki, R., additional, and Kogevinas, M., additional
Published: 2020
Full Text: View/download PDF

26. Setting priorities in environment, climate and health research in Europe

Author: Kogevinas, M., primary, Huss, A., additional, Matthies-Wiesler, F., additional, Desseille, C., additional, Vermeulen, R.C., additional, Peters, A., additional, and Barouki, R., additional
Published: 2020
Full Text: View/download PDF

27. CYTOCHROME P450 2E1 AND ALCOHOL INDUCE ATF4 AND THE INTEGRATED STRESS RESPONSE IN HEPATOCYTES: 354

Author: Magne, L., Blanc, E., Legrand, B., Barouki, R., Rouach, H., and Garlatti, M.
Published: 2008

28. Expression of Inosine Monophosphate Dehydrogenase Type I and Type II After Mycophenolate Mofetil Treatment: A 2-year Follow-up in Kidney Transplantation

Author: Sanquer, S, Maison, P, Tomkiewicz, C, Macquin-Mavier, I, Legendre, C, Barouki, R, and Lang, P
Published: 2008
Full Text: View/download PDF

29. Statement on advancing the assessment of chemical mixtures and their risks for human health and the environment

Author: Drakvik, E., Altenburger, Rolf, Aoki, Y., Backhaus, T., Bahadori, T., Barouki, R., Brack, Werner, Cronin, M.T.D., Demeneix, B., Hougaard Bennekou, S., van Klaveren, J., Kneuer, C., Kolossa-Gehring, M., Lebret, E., Posthuma, L., Reiber, L., Rider, C., Rüegg, J., Testa, G., van der Burg, B., van der Voet, H., Warhurst, A.M., van de Water, B., Yamazaki, K., Öberg, M., Bergman, Å., Drakvik, E., Altenburger, Rolf, Aoki, Y., Backhaus, T., Bahadori, T., Barouki, R., Brack, Werner, Cronin, M.T.D., Demeneix, B., Hougaard Bennekou, S., van Klaveren, J., Kneuer, C., Kolossa-Gehring, M., Lebret, E., Posthuma, L., Reiber, L., Rider, C., Rüegg, J., Testa, G., van der Burg, B., van der Voet, H., Warhurst, A.M., van de Water, B., Yamazaki, K., Öberg, M., and Bergman, Å.
Abstract: The number of anthropogenic chemicals, manufactured, by-products, metabolites and abiotically formed transformation products, counts to hundreds of thousands, at present. Thus, humans and wildlife are exposed to complex mixtures, never one chemical at a time and rarely with only one dominating effect. Hence there is an urgent need to develop strategies on how exposure to multiple hazardous chemicals and the combination of their effects can be assessed. A workshop, “Advancing the Assessment of Chemical Mixtures and their Risks for Human Health and the Environment” was organized in May 2018 together with Joint Research Center in Ispra, EU-funded research projects and Commission Services and relevant EU agencies. This forum for researchers and policy-makers was created to discuss and identify gaps in risk assessment and governance of chemical mixtures as well as to discuss state of the art science and future research needs. Based on the presentations and discussions at this workshop we want to bring forward the following Key Messages:•We are at a turning point: multiple exposures and their combined effects require better management to protect public health and the environment from hazardous chemical mixtures.•Regulatory initiatives should be launched to investigate the opportunities for all relevant regulatory frameworks to include prospective mixture risk assessment and consider combined exposures to (real-life) chemical mixtures to humans and wildlife, across sectors.•Precautionary approaches and intermediate measures (e.g. Mixture Assessment Factor) can already be applied, although, definitive mixture risk assessments cannot be routinely conducted due to significant knowledge and data gaps.•A European strategy needs to be set, through stakeholder engagement, for the governance of combined exposure to multiple chemicals and mixtures. The strategy would include research aimed at scientific advancement in mechanistic understanding and modelling techniques, as well as r
Published: 2019

30. Different chromosomal localization of two adenylyl cyclase genes expressed in human brain

Author: Stengel, D., Parma, J., Gannagé, M. -H., Roeckel, N., Mattei, M. -G., Barouki, R., and Hanoune, J.
Published: 1992
Full Text: View/download PDF

31. Risque médicamenteux : prévention

Author: Barouki, R., Blayac, J.P., Bons, B., Caron, J., Castot, A., Childs, M., Daurat, V., Deligne, J., Delmas, C., Demarez, J.P., Eschwege, E., Garcia-Gibot, A., Girard, F., Guilhot, J., Kreft-Jaïs, C., Lagier, G., Lamarque, V., Lebrun-Vignes, B., Lelouet, A., Maillère, P., Malvy, J.L., Mazraani, M., Moachon-Chauvelot, L., Muzard, D., Olivier, P., Pappo, M., Pastor, E., Riché, C., Sallière, D., Thomas, L., Szafir, Deborah, Lelouët, Hervé, and Imbs, Jean-Louis
Published: 2003
Full Text: View/download PDF

32. Prevention of Drug-Induced Risks

Author: Barouki, R., Blayac, J.P., Bons, B., Caron, J., Castot, A., Childs, M., Daurat, V., Deligne, J., Delmas, C., Demarez, J.P., Eschwege, E., Garcia-Gibot, A., Girard, F., Guilhot, J., Kreft-Jaïs, C., Lagier, G., Lamarque, V., Lebrun-Vignes, B., Lelouet, A., Maillère, P., Malvy, J.L., Mazraani, M., Moachon-Chauvelot, L., Muzard, D., Olivier, P., Pappo, M., Pastor, E., Riché, C., Sallière, D., Thomas, L., Szafir, Deborah, Lelouët, Hervé, and Imbs, Jean-Louis
Published: 2003
Full Text: View/download PDF

33. Determination of bisphenol A and bisphenol S concentrations and assessment of estrogen- and anti-androgen-like activities in thermal paper receipts from Brazil, France, and Spain

Author: Molina-Molina, J.M., primary, Jiménez-Díaz, I., additional, Fernández, M.F., additional, Rodriguez-Carrillo, A., additional, Peinado, F.M., additional, Mustieles, V., additional, Barouki, R., additional, Piccoli, C., additional, Olea, N., additional, and Freire, C., additional
Published: 2019
Full Text: View/download PDF

34. Hormonal Regulation of Cytosolic Aspartate Aminotransferase

Author: HANOUNE, J., primary, AGGERBECK, M., additional, GARLATTI, M., additional, FEILLEUX, S., additional, DAHESHIA, M., additional, and BAROUKI, R., additional
Published: 1991
Full Text: View/download PDF

35. Current EU research activities on combined exposure to multiple chemicals

Author: Bopp, S.K., Barouki, R., Brack, Werner, Dalla Costa, S., Dorne, J.-L.C.M., Drakvik, P.E., Faust, M., Karjalainen, T.K., Kephalopoulos, S., van Klaveren, J., Kolossa-Gehring, M., Kortenkamp, A., Lebret, E., Lettieri, T., Nørager, S., Rüegg, J., Tarazona, J.V., Trier, X., van de Water, B., van Gils, J., Bergman, Å., Bopp, S.K., Barouki, R., Brack, Werner, Dalla Costa, S., Dorne, J.-L.C.M., Drakvik, P.E., Faust, M., Karjalainen, T.K., Kephalopoulos, S., van Klaveren, J., Kolossa-Gehring, M., Kortenkamp, A., Lebret, E., Lettieri, T., Nørager, S., Rüegg, J., Tarazona, J.V., Trier, X., van de Water, B., van Gils, J., and Bergman, Å.
Abstract: Humans and wildlife are exposed to an intractably large number of different combinations of chemicals via food, water, air, consumer products, and other media and sources. This raises concerns about their impact on public and environmental health. The risk assessment of chemicals for regulatory purposes mainly relies on the assessment of individual chemicals. If exposure to multiple chemicals is considered in a legislative framework, it is usually limited to chemicals falling within this framework and co-exposure to chemicals that are covered by a different regulatory framework is often neglected. Methodologies and guidance for assessing risks from combined exposure to multiple chemicals have been developed for different regulatory sectors, however, a harmonised, consistent approach for performing mixture risk assessments and management across different regulatory sectors is lacking. At the time of this publication, several EU research projects are running, funded by the current European Research and Innovation Programme Horizon 2020 or the Seventh Framework Programme. They aim at addressing knowledge gaps and developing methodologies to better assess chemical mixtures, by generating and making available internal and external exposure data, developing models for exposure assessment, developing tools for in silico and in vitro effect assessment to be applied in a tiered framework and for grouping of chemicals, as well as developing joint epidemiological-toxicological approaches for mixture risk assessment and for prioritising mixtures of concern. The projects EDC-MixRisk, EuroMix, EUToxRisk, HBM4EU and SOLUTIONS have started an exchange between the consortia, European Commission Services and EU Agencies, in order to identify where new methodologies have become available and where remaining gaps need to be further addressed. This paper maps how the different projects contribute to the data needs and assessment methodologies and identifies remaining challenges to be fu
Published: 2018

36. ≪ 3es Rencontres médecins-chirurgiens ≫ sur la chirurgie de l’obésité: Le tissu adipeux: une éponge à polluants organiques persistants

Author: Barouki, R. and Clément, K.
Published: 2009
Full Text: View/download PDF

37. The HERA project. An overall introduction of the rationale and organisation

Author: Kogevinas M and Barouki R
Subjects: Global and Planetary Change, Process management, Epidemiology, Health, Toxicology and Mutagenesis, Political science, Public Health, Environmental and Occupational Health, HERA, Pollution
Published: 2019
Full Text: View/download PDF

38. Multi-omics Analysis reveals that co-exposure to phthalates and metals disturbs urea cycle and choline metabolism

Author: Sarigiannis, D., primary, Papaioannou, N., additional, Kapretsos, N., additional, Gabriel, C., additional, Distel, E., additional, de Oliveira, E., additional, Karakitsios, S., additional, Aggerbeck, M., additional, and Barouki, R., additional
Published: 2018
Full Text: View/download PDF

39. Epigenetics as a mechanism linking developmental exposures to long-term toxicity

Author: Barouki, R., primary, Melén, E., additional, Herceg, Z., additional, Beckers, J., additional, Chen, J., additional, Karagas, M., additional, Puga, A., additional, Xia, Y., additional, Chadwick, L., additional, Yan, W., additional, Audouze, K., additional, Slama, R., additional, Heindel, J., additional, Grandjean, P., additional, Kawamoto, T., additional, and Nohara, K., additional
Published: 2018
Full Text: View/download PDF

40. Biallelic Mutations in LIPT2 Cause a Mitochondrial Lipoylation Defect Associated with Severe Neonatal Encephalopathy

Author: Habarou, F., Hamel, Y., Haack, T.B., Feichtinger, R.G., Lebigot, E., Marquardt, I., Busiah, K., Laroche, C., Madrange, M., Grisel, C., Pontoizeau, C., Eisermann, M., Boutron, A., Chretien, D., Chadefaux-Vekemans, B., Barouki, R., Bole-Feysot, C., Nitschke, P., Goudin, N., Boddaert, N., Nemazanyy, I., Delahodde, A., Kolker, S., Rodenburg, R.J.T., Korenke, G.C., Meitinger, T., Strom, T.M., Prokisch, H., Rotig, A., Ottolenghi, C., Mayr, J.A., Lonlay, P. de, Habarou, F., Hamel, Y., Haack, T.B., Feichtinger, R.G., Lebigot, E., Marquardt, I., Busiah, K., Laroche, C., Madrange, M., Grisel, C., Pontoizeau, C., Eisermann, M., Boutron, A., Chretien, D., Chadefaux-Vekemans, B., Barouki, R., Bole-Feysot, C., Nitschke, P., Goudin, N., Boddaert, N., Nemazanyy, I., Delahodde, A., Kolker, S., Rodenburg, R.J.T., Korenke, G.C., Meitinger, T., Strom, T.M., Prokisch, H., Rotig, A., Ottolenghi, C., Mayr, J.A., and Lonlay, P. de
Abstract: Item does not contain fulltext, Lipoate serves as a cofactor for the glycine cleavage system (GCS) and four 2-oxoacid dehydrogenases functioning in energy metabolism (alpha-oxoglutarate dehydrogenase [alpha-KGDHc] and pyruvate dehydrogenase [PDHc]), or amino acid metabolism (branched-chain oxoacid dehydrogenase, 2-oxoadipate dehydrogenase). Mitochondrial lipoate synthesis involves three enzymatic steps catalyzed sequentially by lipoyl(octanoyl) transferase 2 (LIPT2), lipoic acid synthetase (LIAS), and lipoyltransferase 1 (LIPT1). Mutations in LIAS have been associated with nonketotic hyperglycinemia-like early-onset convulsions and encephalopathy combined with a defect in mitochondrial energy metabolism. LIPT1 deficiency spares GCS deficiency and has been associated with a biochemical signature of combined 2-oxoacid dehydrogenase deficiency leading to early death or Leigh-like encephalopathy. We report on the identification of biallelic LIPT2 mutations in three affected individuals from two families with severe neonatal encephalopathy. Brain MRI showed major cortical atrophy with white matter abnormalities and cysts. Plasma glycine was mildly increased. Affected individuals' fibroblasts showed reduced oxygen consumption rates, PDHc, alpha-KGDHc activities, leucine catabolic flux, and decreased protein lipoylation. A normalization of lipoylation was observed after expression of wild-type LIPT2, arguing for LIPT2 requirement in intramitochondrial lipoate synthesis. Lipoic acid supplementation did not improve clinical condition nor activities of PDHc, alpha-KGDHc, or leucine metabolism in fibroblasts and was ineffective in yeast deleted for the orthologous LIP2.
Published: 2017

41. Hyperprolinemia in Type 2 Glutaric Aciduria and MADD-Like Profiles

Author: Pontoizeau, C., Habarou, F., Brassier, A., Veauville-Merllie, A., Grisel, C., Arnoux, J. B., Vianey-Saban, Christine, Barouki, R., Chadefaux-Vekemans, B., Acquaviva, C., Lonlay, P., Ottolenghi, C., Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon-Institut National de la Recherche Agronomique (INRA)
Subjects: [SDV]Life Sciences [q-bio]
Abstract: International audience; Classical neonatal-onset glutaric aciduria type 2 (MAD deficiency) is a severe disorder of mitochondrial fatty acid oxidation associated with poor survival. Secondary dysfunction of acyl-CoA dehydrogenases may result from deficiency for riboflavin transporters, leading to severe disorders that, nevertheless, are treatable by riboflavin supplementation. In the last 10 years, we identified nine newborns with biochemical features consistent with MAD deficiency, only four of whom survived past the neonatal period. A likely iatrogenic cause of riboflavin deficiency was found in two premature newborns having parenteral nutrition, one of whom recovered upon multivitamin supplementation, whereas the other died before diagnosis. Four other patients had demonstrated mutations involving ETF or ETF-DH flavoproteins, whereas the remaining three patients presumably had secondary deficiencies of unknown mechanism. Interestingly, six newborns among the seven tested for plasma amino acids had pronounced hyperprolinemia. In one case, because the initial diagnostic workup did not include organic acids and acylcarnitine profiling, clinical presentation and hyperprolinemia suggested the diagnosis. Analysis of our full cohort of \textgreater50,000 samples from \textgreater30,000 patients suggests that the proline/alanine ratio may be a good marker of MAD deficiency and could contribute to a more effective management of the treatable forms.
Published: 2016
Full Text: View/download PDF

42. The Mediterranean region under climate change : a scientific update

Author: Guégan, Jean-François (coord.), Barouki, R. (coord.), Annesi-Maesano, I. (coord.), Thiébault, S. (ed.), and Moatti, Jean-Paul (ed.)
Subjects: EVENEMENT EXTREME, EPIDEMIOLOGIE, MALADIE, RECOMMANDATION, VECTEUR, AEROSOL, RISQUE SANITAIRE, RECHERCHE SCIENTIFIQUE, FACTEUR ANTHROPIQUE, INCENDIE, FACTEUR CLIMATIQUE, PRECIPITATION, CHANGEMENT CLIMATIQUE, SANTE, INFECTION, POLLUTION ATMOSPHERIQUE, MOUSTIQUE, SYNTHESE, TEMPERATURE
Published: 2016

43. The Mediterranean region under climate change : a scientific update

Author: Guégan, Jean-François, Barouki, R., Annesi-Maesano, I., Thiébault, S. (ed.), and Moatti, Jean-Paul (ed.)
Subjects: EPIDEMIOLOGIE, MALADIE, RECOMMANDATION, FACTEUR CLIMATIQUE, CHANGEMENT CLIMATIQUE, SANTE, RECHERCHE SCIENTIFIQUE, POLITIQUE DE SANTE
Published: 2016

44. The Mediterranean region under climate change : a scientific update : abridged English/French version = La Méditerranée face au changement climatique : état des lieux de la recherche : version abrégée bilingue (anglais/français)

Author: Thiébault, S. (ed.), Moatti, Jean-Paul (ed.), Ducrocq, V. (coord.), Gaume, E. (coord.), Dulac, F. (coord.), Hamonou, E. (coord.), Shin, Yunne-Jai (coord.), Guiot, J. (coord.), Cramer, W. (coord.), Boulet, Gilles (coord.), Guégan, Jean-François (coord.), Barouki, R. (coord.), Annesi-Maesano, I. (coord.), Marty, P. (coord.), Torquebiau, E. (coord.), Soussana, J.F. (coord.), Aumeeruddy-Thomas, Y. (coord.), Chotte, Jean-Luc (coord.), and Lacroix, D. (coord.)
Subjects: SOL, AGRICULTURE, SECURITE ALIMENTAIRE, ECOSYSTEME, BIODIVERSITE, ZONE COTIERE, HISTOIRE, RECHERCHE SCIENTIFIQUE, RESILIENCE, RESSOURCES EN EAU, VULNERABILITE, CLIMATOLOGIE, PREVENTION, CHANGEMENT CLIMATIQUE, MILIEU MARIN, SANTE, GESTION DU RISQUE, GESTION DE L'ENVIRONNEMENT, IMPACT SOCIOECONOMIQUE, ELEVAGE, QUALITE DE L'AIR, ADAPTATION, IMPACT SUR L'ENVIRONNEMENT, PROSPECTIVE
Abstract: Cet ouvrage, publié par l'Alliance nationale de recherche sur l'environnement (Allenvi) à l'occasion de la 22e Conférence des Parties de la Convention Cadre des Nations unies sur le changement climatique (COP22) de Marrakech, est le fruit de la mobilisation de chercheurs et d'universitaires des deux rives de la Méditerranée. Il constitue une synthèse scientifique exceptionnelle sur les mécanismes du changement climatique, ses impacts sur l'environnement, l'économie, la santé et les sociétés de la Méditerranée. Il représente par ailleurs un précieux outil pour élaborer des réponses, fondées sur l' « évidence scientifique », en matière d'adaptation, de conservation des ressources, de solutions ou de prévention des risques. Mettant en exergue toute la complexité de l'environnement méditerranéen, cet ouvrage est une contribution scientifique majeure à la question climatique, au croisement des questionnements scientifiques dans une perspective de décloisonnement disciplinaire.
Published: 2016

45. La citrulline induit-elle la « brunisation » du tissu adipeux blanc pour participer à la dépense énergétique ?

Author: Noirez, P., primary, Joffin, N., additional, Bamba, J., additional, Durant, S., additional, Barouki, R., additional, Jaubert, A.-M., additional, and Forest, C., additional
Published: 2016
Full Text: View/download PDF

46. Chromosomal localization of human aspartate aminotransferase genes by in situ hybridization

Author: Pol, S., Bousquet-Lemercier, B., Pavé-Preux, M., Bulle, F., Passage, E., Hanoune, J., Mattei, M. G., and Barouki, R.
Published: 1989
Full Text: View/download PDF

47. Pregnancy, endocrinian troublemakers, sweeteners and chemical products: what do we know in 2011?

Author: Barouki, R., Fenichel, P., Houdeau, Eric, Buhler, Eve Anne, INSERM UMR S-747, Centre Hospitalier Universitaire de Nice (CHU Nice), Endocrinologie & Toxicologie de la Barrière Intestinale (ToxAlim-ENTeRisk), ToxAlim (ToxAlim), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Ecole d'Ingénieurs de Purpan (INPT - EI Purpan), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Recherche Agronomique (INRA)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Recherche Agronomique (INRA), and ProdInra, Migration
Subjects: [SDV] Life Sciences [q-bio], RISK, [SDV]Life Sciences [q-bio], CELLS, BREAST-CANCER, CHILDREN, HEALTH, EXPOSURE, ComputingMilieux_MISCELLANEOUS, BISPHENOL-A
Abstract: National audience
Published: 2012

48. Predictive toxicology: the paths of the future

Author: Detilleux, Ph, Vallier, L, Legallais, C, Leclerc, E, Prot J, M, Choucha, L, Baudoin, R, Dufresne, M, Gautier, A, Carpentier, B, Mansuy, D, Pery, Alexandre R.R., Brochot, C, Manivet, Ph, Rabilloud, Thierry, Spire, C, Coumoul, Xavier, Junot, Ch, Laprevote, O, Le Pape, A, Tourneur, E, Ben Mkaddem, S, Chassin, C, Aloulou, M, Goujon J, M, Hertif, A, Ouali, N, Vimont, S, Monteiro, R, Rondeau, E, Elbim, C, Werts, C, Vandewalle, A, Pedruzzi, E, Coant, N, Bens, M, Cluzeaud, F, Ogier-Denis, E, Pongnimitprasert, N, Babin-Chevaye, C, Fay, M, Bernard, M, Dupuy, C, Ei Benna, J, Gougerot-Pocidale M, A, Braut-Boucher, F, Pinton, Philippe, Lucioli, Joelma, Tsybulskyy, D, Joly, Baptiste, Laffitte, J, Bourges-Abella, N, Oswald, Isabelle P., Kolf-Clauw, Martine, Pierre, St, Bats A, S, Chevalier, Aline, Bui L, Ch, Ambolet-Camoit, A, Garlatti, M, Aggerbeck, M, Barouki, R, Al Khansa, I, Blanck, O, Guillouzo, A, Bars, R, Rouas, C, Bensoussan, H, Suhard, D, Tessier, C, Grandcolas, L, Pallardy, M, Gueguen, Y, Sparfel, L, Pinel-Marie M, L, Boize, M, Koscielny, S, Desmots, S, Fardel, O, Alvergnas, M, Rouleau, A, Lucchi, G, Mantion, G, Heyd, B, Richert, L, Ducoroy, P, Martin, H, Val, St, Martinon, L, Cachier, H, Yahyaoui, A, Marfaing, H, Baeza-Squiban, A, Martin-Chouly, Corinne, Bonvallet, M, Morzadec, C, Vernhet, L, Baverel, G, El Hage, M, Nazaret, R, Conjard-Duplany, A, Ferrier, B, Martin, G, Legendre, A, Lecomte, Anthony, Froment, P, Habert, R, Lemazurier, E, Robinel, F, Dupont, O, Sanfins, E, Dairou, J, Chaffotte A, F, Busi, F, Rodrigues Lima, F, Dupret J, M, Mayati, A, Le Ferrec, Eric, Levoin, N, Paris, H, Uriac, Ph, N'Diaye, M, Lagadic-Gossmann, D, Assemat, E, Boublil, L, Borot M, C, Marano, F, Martiny V, Y, Moroy, G, Badel, A, Miteva M, A, Hussain, S, Ferecatu, I, Borot, C, Andreau, K, Boland, S, Leroux, M, Zucchini-Pascal, Nathalie, Peyre, L, Rahmani, Roger, Buron, N, Porcedou, M, Fromenty, B, Borgne-Sanchez, A, Rogue, A, Claude, N, Le Guével, Rémy, Institut National de l'Environnement Industriel et des Risques (INERIS), Laboratoire pharmaceutique Biologie Servier, Biologie Servier, Pharmacologie, toxicologie et signalisation cellulaire (U747), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Faculté de Médecine Xavier Bichat, Centre de recherche biomédicale Bichat-Beaujon (CRB3), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Unité de recherche Pharmacologie-Toxicologie (UPT), Institut National de la Recherche Agronomique (INRA), Toxicité environnementale, cibles thérapeutiques, signalisation cellulaire (T3S - UMR_S 1124), Cytokines, chimiokines et immunopathologie, Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Fonctions et dysfonctions épithéliales - UFC (EA 4267) (FDE), Université de Franche-Comté (UFC), Plate-forme Protéomique CLIPP - Clinical and Innovation Proteomic Platform [Dijon] (CLIPP), Franche-Comté Électronique Mécanique, Thermique et Optique - Sciences et Technologies (UMR 6174) (FEMTO-ST), Université de Franche-Comté (UFC)-Centre National de la Recherche Scientifique (CNRS)-Ecole Nationale Supérieure de Mécanique et des Microtechniques (ENSMM)-Université de Technologie de Belfort-Montbeliard (UTBM)-Université de Franche-Comté (UFC)-Centre National de la Recherche Scientifique (CNRS)-Ecole Nationale Supérieure de Mécanique et des Microtechniques (ENSMM)-Université de Technologie de Belfort-Montbeliard (UTBM)-Institut de Chimie Moléculaire de l'Université de Bourgogne [Dijon] (ICMUB), Université de Bourgogne (UB)-Centre National de la Recherche Scientifique (CNRS)-Université de Bourgogne (UB)-Centre National de la Recherche Scientifique (CNRS), Laboratoire des Sciences du Climat et de l'Environnement [Gif-sur-Yvette] (LSCE), Université Paris-Saclay-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Centre National de la Recherche Scientifique (CNRS), Cellules Souches et Radiations (SCSR (U967 / UMR-E_008)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris-Sud - Paris 11 (UP11), Laboratoire Bioprojet, Institut des Sciences Chimiques de Rennes (ISCR), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées - Rennes (INSA Rennes), Institut National des Sciences Appliquées (INSA)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées (INSA)-Ecole Nationale Supérieure de Chimie de Rennes-Centre National de la Recherche Scientifique (CNRS), Unité de Biologie Fonctionnelle et Adaptative (BFA (UMR_8251 / U1133)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Diderot - Paris 7 (UPD7), Mitologics SAS, Hôpital Robert Debré, Biomécanique et Bioingénierie (BMBI), Université de Technologie de Compiègne (UTC)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de radiotoxicologie expérimentale (IRSN/DRPH/SRBE/LRTOX), Service de RadioBiologie et d'Epidémiologie (IRSN/DRPH/SRBE), Institut de Radioprotection et de Sûreté Nucléaire (IRSN)-Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Université de Technologie de Belfort-Montbeliard (UTBM)-Ecole Nationale Supérieure de Mécanique et des Microtechniques (ENSMM)-Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université de Technologie de Belfort-Montbeliard (UTBM)-Ecole Nationale Supérieure de Mécanique et des Microtechniques (ENSMM)-Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Institut de Chimie Moléculaire de l'Université de Bourgogne [Dijon] (ICMUB), Université de Bourgogne (UB)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université de Bourgogne (UB)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut national des sciences de l'Univers (INSU - CNRS)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Stabilité génétique, Cellules Souches et Radiations (SCSR (U_967)), Université Paris-Sud - Paris 11 (UP11)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Université de Rennes (UR)-Institut National des Sciences Appliquées - Rennes (INSA Rennes), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Ecole Nationale Supérieure de Chimie de Rennes (ENSCR)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université Paris Descartes - Paris 5 (UPD5)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Sud - Paris 11 (UP11), Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )-Institut National de la Santé et de la Recherche Médicale (INSERM)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Université d'Angers (UA), Université de Technologie de Belfort-Montbeliard (UTBM)-Ecole Nationale Supérieure de Mécanique et des Microtechniques (ENSMM)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre National de la Recherche Scientifique (CNRS)-Université de Technologie de Belfort-Montbeliard (UTBM)-Ecole Nationale Supérieure de Mécanique et des Microtechniques (ENSMM)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie Moléculaire de l'Université de Bourgogne [Dijon] (ICMUB), Institut national des sciences de l'Univers (INSU - CNRS)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Université Paris-Sud - Paris 11 (UP11)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Ecole Nationale Supérieure de Chimie de Rennes (ENSCR)-Institut National des Sciences Appliquées - Rennes (INSA Rennes), Institut National des Sciences Appliquées (INSA)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées (INSA), Université Paris-Sud - Paris 11 (UP11)-Université Paris Diderot - Paris 7 (UPD7)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National des Sciences Appliquées - Rennes (INSA Rennes), Institut National des Sciences Appliquées (INSA)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées (INSA)-Université de Rennes (UNIV-RENNES)-Centre National de la Recherche Scientifique (CNRS)-Ecole Nationale Supérieure de Chimie de Rennes-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES), Institut National de l'Environnement Industriel et des Risques ( INERIS ), Physiologie Cellulaire des Regulations Hormonales, Nutritionnelles et Pharmacologiques, Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Centre de recherche biomédicale Bichat-Beaujon ( CRB3 ), Université Paris Diderot - Paris 7 ( UPD7 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Unité de recherche Pharmacologie-Toxicologie ( UPT ), Institut National de la Recherche Agronomique ( INRA ), Toxicologie, Pharmacologie et Signalisation Cellulaire ( U1124 ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Centre National de la Recherche Scientifique ( CNRS ), Université Paris-Sud - Paris 11 ( UP11 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Service de biostatistique et d'épidémiologie ( SBE ), Institut Gustave Roussy ( IGR ) -Institut Gustave Roussy ( IGR ), Institut de recherche, santé, environnement et travail ( Irset ), Université d'Angers ( UA ) -Université de Rennes 1 ( UR1 ), Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -École des Hautes Études en Santé Publique [EHESP] ( EHESP ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ) -Université des Antilles ( UA ), Fonctions et dysfonctions épithéliales - UFC (EA 4267) ( FDE ), Université de Franche-Comté ( UFC ), Plate-forme Protéomique CLIPP - Clinical and Innovation Proteomic Platform [Dijon] ( CLIPP ), Franche-Comté Électronique Mécanique, Thermique et Optique - Sciences et Technologies (UMR 6174) ( FEMTO-ST ), Université de Franche-Comté ( UFC ) -Centre National de la Recherche Scientifique ( CNRS ) -Ecole Nationale Supérieure de Mécanique et des Microtechniques ( ENSMM ) -Université de Technologie de Belfort-Montbeliard ( UTBM ) -Université de Franche-Comté ( UFC ) -Centre National de la Recherche Scientifique ( CNRS ) -Ecole Nationale Supérieure de Mécanique et des Microtechniques ( ENSMM ) -Université de Technologie de Belfort-Montbeliard ( UTBM ) -Institut de Chimie Moléculaire de l'Université de Bourgogne [Dijon] ( ICMUB ), Université de Bourgogne ( UB ) -Centre National de la Recherche Scientifique ( CNRS ) -Université de Bourgogne ( UB ) -Centre National de la Recherche Scientifique ( CNRS ), Laboratoire des Sciences du Climat et de l'Environnement [Gif-sur-Yvette] ( LSCE ), Université Paris-Saclay-Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ) -Université de Versailles Saint-Quentin-en-Yvelines ( UVSQ ) -Centre National de la Recherche Scientifique ( CNRS ), Cellules Souches et Radiations ( SCSR - U 967 ), Université Paris-Sud - Paris 11 ( UP11 ) -Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ) -Université Paris Diderot - Paris 7 ( UPD7 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Institut des Sciences Chimiques de Rennes ( ISCR ), Université de Rennes 1 ( UR1 ), Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -Ecole Nationale Supérieure de Chimie de Rennes-Institut National des Sciences Appliquées ( INSA ) -Centre National de la Recherche Scientifique ( CNRS ), Biologie Fonctionnelle et Adaptative ( BFA ), and Université Paris Diderot - Paris 7 ( UPD7 ) -Centre National de la Recherche Scientifique ( CNRS )
Subjects: [ SDV ] Life Sciences [q-bio], [SDV.TOX]Life Sciences [q-bio]/Toxicology, [SDV]Life Sciences [q-bio], ComputingMilieux_MISCELLANEOUS
Abstract: National audience
Published: 2010

49. Pyruvate carboxylase deficiency: An underestimated cause of lactic acidosis

Author: Habarou, F., primary, Brassier, A., additional, Rio, M., additional, Chrétien, D., additional, Monnot, S., additional, Barbier, V., additional, Barouki, R., additional, Bonnefont, J.P., additional, Boddaert, N., additional, Chadefaux-Vekemans, B., additional, Le Moyec, L., additional, Bastin, J., additional, Ottolenghi, C., additional, and de Lonlay, P., additional
Published: 2015
Full Text: View/download PDF

50. Toxicologie predictive: les voies du futur

Author: Ph Detilleux, Vallier, L., Legallais, C., Leclerc, E., M Prot J, Choucha, L., Baudoin, R., Dufresne, M., Gautier, A., Carpentier, B., Mansuy, D., Pery, Alexandre R. R., Brochot, C., Ph Manivet, Thierry Rabilloud, Spire, C., Xavier Coumoul, Ch Junot, Laprevote, O., Le Pape, A., Ronan Le Guével, Tourneur, E., Ben Mkaddem, S., Chassin, C., Aloulou, M., M Goujon J, Hertif, A., Ouali, N., Vimont, S., Monteiro, R., Rondeau, E., Elbim, C., Werts, C., Vandewalle, A., Pedruzzi, E., Coant, N., Bens, M., Cluzeaud, F., Ogier-Denis, E., Pongnimitprasert, N., Babin-Chevaye, C., Fay, M., Bernard Fromenty, Dupuy, C., Ei Benna, J., A Gougerot-Pocidale M, Braut-Boucher, F., Ph Pinton, Lucioli, J., Tsybulskyy, D., Baptiste Joly, Laffitte, J., Bourges-Abella, N., P Oswald I, Kolf-Clauw, M., St Pierre, S Bats A, Aline Chevalier, Ch Bui L, Ambolet-Camoit, A., Garlatti, M., Aggerbeck, M., Barouki, R., Al Khansa, I., Blanck, O., Guillouzo, A., Bars, R., Rouas, C., Bensoussan, H., Suhard, D., Tessier, C., Grandcolas, L., Pallardy, M., Gueguen, Y., Sparfel, L., L Pinel-Marie M, Boize, M., Koscielny, S., Desmots, S., Fardel, O., Alvergnas, M., Rouleau, A., Lucchi, G., Mantion, G., Heyd, B., Richert, L., Ducoroy, P., Martin, H., St Val, Martinon, L., Cachier, H., Yahyaoui, A., Marfaing, H., Baeza-Squiban, A., Corinne Martin-Chouly, Bonvallet, M., Morzadec, C., Vernhet, L., Baverel, G., El Hage, M., Nazaret, R., Conjard-Duplany, A., Ferrier, B., Martin, G., Legendre, A., Lecomte, A., Froment, P., Habert, R., Lemazurier, E., Robinel, F., Dupont, O., Sanfins, E., Dairou, J., F Chaffotte A, Busi, F., Rodrigues Lima, F., M Dupret J, Mayati, A., Eric Le Ferrec, Levoin, N., Paris, H., Ph Uriac, Diaye, M. N., Lagadic-Gossmann, D., Assemat, E., Boublil, L., C Borot M, Marano, F., Y Martiny V, Moroy, G., Badel, A., A Miteva M, Hussain, S., Ferecatu, I., Borot, C., Andreau, K., Boland, S., Leroux, M., Zucchini-Pascal, N., Peyre, L., Rahmani, R., Buron, N., Porcedou, M., Fromenty, B., Borgne-Sanchez, A., Rogue, A., Claude, N., and Jonchère, Laurent
Subjects: [SDV] Life Sciences [q-bio], [SDV.TOX] Life Sciences [q-bio]/Toxicology
Published: 2010

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Region

Database

Publisher

428 results on '"Barouki, R."'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources